| Keyhan Farkhondepay-aryah, MD | |
|
1550 Oak St, Suite 7, Eugene, OR 97401-7701 | |
| (541) 687-1927 | |
| (541) 683-8779 |
| Full Name | Keyhan Farkhondepay-aryah |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 39 Years |
| Location | 1550 Oak St, Eugene, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598763716 | NPI | - | NPPES |
| 041389 | Medicaid | OR | |
| 180018630 | Other | RAILROAD MEDICARE | |
| 180039026 | Other | MEDICARE, RR | |
| 180039025 | Other | MEDICARE RR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD17703 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Eye Consultants Llc | 9638142904 | 7 |
News Archive
Patients who choose to receive alternative therapy as treatment for curable cancers instead of conventional cancer treatment have a higher risk of death, according to researchers from the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine and Yale Cancer Center.
As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary, according to a new study by researchers at Hospital for Special Surgery. These medications are used to treat a variety of inflammatory diseases, including rheumatoid arthritis, and better timing of withdrawal prior to surgery might minimize the risk of disease flares.
The apparent dearth of research on hepatitis B and C testing in many European countries could be hampering efforts to identify infected individuals, according to results from a comprehensive review of 136 studies presented today at The International Liver Congress 2015.
A highly resistant strain of rapidly progressive human immunodeficiency virus (HIV) has been diagnosed for the first time in a New York City resident who had not previously undergone antiviral drug treatment, according to the Department of Health and Mental Hygiene (DOHMH).
Three studies in acid maltase deficiency (AMD, or Pompe's disease) being conducted by Genzyme of Cambridge, Mass., with support from MDA, are progressing on schedule, the company says.
› Verified 2 days ago
| Entity Name | Oregon Eye Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023199734 PECOS PAC ID: 9638142904 Enrollment ID: O20040816000305 |
News Archive
Patients who choose to receive alternative therapy as treatment for curable cancers instead of conventional cancer treatment have a higher risk of death, according to researchers from the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine and Yale Cancer Center.
As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary, according to a new study by researchers at Hospital for Special Surgery. These medications are used to treat a variety of inflammatory diseases, including rheumatoid arthritis, and better timing of withdrawal prior to surgery might minimize the risk of disease flares.
The apparent dearth of research on hepatitis B and C testing in many European countries could be hampering efforts to identify infected individuals, according to results from a comprehensive review of 136 studies presented today at The International Liver Congress 2015.
A highly resistant strain of rapidly progressive human immunodeficiency virus (HIV) has been diagnosed for the first time in a New York City resident who had not previously undergone antiviral drug treatment, according to the Department of Health and Mental Hygiene (DOHMH).
Three studies in acid maltase deficiency (AMD, or Pompe's disease) being conducted by Genzyme of Cambridge, Mass., with support from MDA, are progressing on schedule, the company says.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Keyhan Farkhondepay-aryah, MD 1550 Oak St, Suite 7, Eugene, OR 97401-7701 Ph: (541) 687-1927 | Keyhan Farkhondepay-aryah, MD 1550 Oak St, Suite 7, Eugene, OR 97401-7701 Ph: (541) 687-1927 |
News Archive
Patients who choose to receive alternative therapy as treatment for curable cancers instead of conventional cancer treatment have a higher risk of death, according to researchers from the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine and Yale Cancer Center.
As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary, according to a new study by researchers at Hospital for Special Surgery. These medications are used to treat a variety of inflammatory diseases, including rheumatoid arthritis, and better timing of withdrawal prior to surgery might minimize the risk of disease flares.
The apparent dearth of research on hepatitis B and C testing in many European countries could be hampering efforts to identify infected individuals, according to results from a comprehensive review of 136 studies presented today at The International Liver Congress 2015.
A highly resistant strain of rapidly progressive human immunodeficiency virus (HIV) has been diagnosed for the first time in a New York City resident who had not previously undergone antiviral drug treatment, according to the Department of Health and Mental Hygiene (DOHMH).
Three studies in acid maltase deficiency (AMD, or Pompe's disease) being conducted by Genzyme of Cambridge, Mass., with support from MDA, are progressing on schedule, the company says.
› Verified 2 days ago
Scott Cherne, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1125 Darlene Ln, Suite 100, Eugene, OR 97401 Phone: 541-343-5000 Fax: 541-344-9478 | |
Blake V Fausett, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2550 Willakenzie Rd, Eugene, OR 97401 Phone: 541-434-0922 | |
Walter Benjamin Kunz, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1550 Oak St, Suite 7, Eugene, OR 97401 Phone: 541-687-1927 | |
Dr. Anthony Grillo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1125 Darlene Ln, Eugene, OR 97401 Phone: 541-343-5000 | |
Peter Wyzinski, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1125 Darlene Ln, Suite 100, Eugene, OR 97401 Phone: 541-343-5000 Fax: 541-344-9478 | |
Mr. Allan Armstrong Hunter Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 360 S Garden Way Ste 101a, Eugene, OR 97401 Phone: 541-237-8400 Fax: 541-237-8850 | |
Matthew D Neale, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 992 Country Club Rd, Ste101, Eugene, OR 97401 Phone: 541-687-1715 Fax: 541-687-1690 |